20.500.12556/DKUM-89282 COVID-19 vaccination hesitancy among people with chronic neurological disorders a position paper Background and purpose Health risks associated with SARS-CoV-2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID-19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID-19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID-19 pandemic but puts individual lives at risk, as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID-19 course. Methods In this position paper, the NeuroCOVID-19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage, and formulates strategies to overcome vaccination hesitancy. A survey among the Task Force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation. Results The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS-CoV-2 vaccination. The prevailing concerns included the chance of worsening the pre-existing neurological condition, vaccination-related adverse events, and drug interaction. Conclusions The EAN NeuroCOVID-19 Task Force reinforces the key role of neurologists as advocates of COVID-19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID-19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, its concerns, and the emergence of potential safety signals. advocacy COVID-19 infectious disease prevention neurological disorders SARS-CoV-2 vaccination vaccine skepticism zagovorništvo preprečevanje nalezljivih bolezni nevrološke motnje cepljenje skepticizem glede cepiva true false true Blackwell Science Angleški jezik Slovenski jezik Znanstveno delo 2024-07-02 13:52:52 2024-07-02 14:22:34 2024-07-03 04:17:27 0000-00-00 00:00:00 2022 0 0 Str. 2163-2172 Št. 8 Letn. 29 Aug. 2022 0000-00-00 Zaloznikova Objavljeno NiDoloceno 2022-04-12 2022-04-15 2022-04-23 616.8 108168963 10.1111/ene.15368 1468-1331 Rakusa-2022-COVID-19_vaccination_hesitancy_amo.pdf Rakusa-2022-COVID-19_vaccination_hesitancy_amo.pdf 1 AEEB9CC074F4F26A358E98FDC412BC39 52332ff5fb1f4562764c12f7a6fcbcb2a59365763dfe9a6aa98c549152a3067b 78b97fa1-386d-11ef-9e98-00155d000105 https://dk.um.si/Dokument.php?lang=slv&id=181003 https://doi.org/10.1111/ene.15368 1 a75113d5-3869-11ef-9e98-00155d000105 https://dk.um.si/Dokument.php?lang=slv&id=181001 Medicinska fakulteta 0 0 0